Key facts
- This page summarizes Michael Egholm's Form 4 filing for STANDARD BIOTOOLS INC. (LAB).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 24 Mar 2025, 18:31.
Michael Egholm - 21 Mar 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)
- Signature
- /s/ Michael Egholm by Tomone Tanaka, Attorney-in-Fact
- Issuer symbol
- LAB
- Transactions as of
- 21 Mar 2025
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 24 Mar 2025, 18:31:57 UTC
- Previous filing
- 24 Feb 2025
- Next filing
- 08 Apr 2025
- SEC
- View on sec.gov
Key filing fact
Michael Egholm filed Form 4 for STANDARD BIOTOOLS INC. (LAB) on 24 Mar 2025.
Change
- Previous filing in this sequence was filed on 24 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
LAB
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,188,333
- Change %
- +82%
- Price
- $0.000000
- Shares after
- 2,636,006
- Date
- 21 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
LAB
transaction
Derivative
Stock Option (Right to buy)
Award
- Transaction value
- $0
- Shares
- +1,782,500
- Change %
- Price
- $0.000000
- Shares after
- 1,782,500
- Date
- 21 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,782,500
- Exercise price
- $1.21
- Footnotes
- F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2025 and the remaining RSUs vesting in equally quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| F2 | The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2025, with the remaining shares vesting in equally quarterly installments, thereafter, subject to the Reporting Person's continued service through the applicable vesting date. |